National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J05AB11	VALACICLOVIR ARROW	G	Valaciclovir - 500mg	500mg	Tablet, film coated, breakable	2,889,261 L.L
L01CD02	DOCETAXEL GP PHARM	G	Docetaxel - 40mg/ml	20mg/0.5ml	Injectable concentrated solution+diluent	4,567,721 L.L
L01XG01	BORTEZOMIB SPC	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	15,743,401 L.L
L04AX04	LENOMA	G	Lenalidomide - 25mg	25mg	Capsule, hard	15,343,847 L.L
M05BA06	BONAFOR	G	Ibandronic acid (monosodium monohydrate) - 150mg	150mg	Tablet, film coated	383,955 L.L
N03AX09	LAMOTRIGINE BIOGARAN	G	Lamotrigine - 100mg	100mg	Tablet, dispersible	1,233,647 L.L
N05AX12	PIRIFY	G	Aripiprazole - 15mg	15mg	Tablet	795,555 L.L
N07CA03	ZINASEN	G	Flunarizine (HCl) - 10mg	10mg	Tablet	599,354 L.L
S02CA06	AURICULARUM	G	Dexamethasone (sodium phosphate) - 10mg, Nystatin - 1,000,000IU, Oxytetracycline HCl - 90,000IU, Polymyxin B sulfate - 100,000IU		Powder for suspension + solvent	755,239 L.L
A10BB12	DIAMERIL	G	Glimepiride - 4mg	4mg	Tablet	322,522 L.L
B05BB02	5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml		Injectable solution	180,421 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS LS3	G	Potassium chloride - K+:2.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.60 mmol/l, Sodium acetate - Cl-:112 mmol/l, Sodium chloride - Na+:140 mmol/l		Injectable solution	L.L
C08CA01	AMLINE	G	Amlodipine - 10mg	10mg	Tablet	662,962 L.L
C09DB07	CANDAM	G	Candesartan cilexetil - 16mg, Amlodipine - 5mg		Capsule, hard	1,376,095 L.L
D03BA	SERODASE	G	Serratiopeptidase - 5mg	5mg	Tablet, enteric coated	460,938 L.L
J01DH02	AROPEM	G	Meropenem (trihydrate) - 0.5g	0.5g	Injectable powder for solution	995,723 L.L
J05AB11	VALCYK BENTA	G	Valaciclovir - 500mg	500mg	Tablet, film coated	4,318,214 L.L
L01XG01	VELZOME	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	17,462,517 L.L
L04AX04	LIDAMID 25	G	Lenalidomide - 25mg	25mg	Capsule	87,161,381 L.L
N03AX09	LAMOTRIGINE NORMON	G	Lamotrigine - 100mg	100mg	Tablet, dispersible/ chewable	2,284,532 L.L
N05AX12	XALIPRO	G	Aripiprazole - 15mg	15mg	Tablet	2,418,917 L.L
N07X	CEREBROLYSIN	G	Cerebrolysin - 215.2mg/ml	215.2mg/ml	Injectable concentrated solution	2,303,346 L.L
R05CB06	MUCOVIC FORTE	G	Ambroxol HCl - 30mg/5ml	30mg/5ml	Solution, sugar free	293,086 L.L
S02CA07	PAROTICIN	G	Fludrocortisone acetate - 1mg/ml, Polymyxin B (sulfate) - 10.000IU/ml, Lidocaine - 50mg/ml		Drops solution	319,835 L.L
A10BB12	GLIM	G	Glimepiride - 4mg	4mg	Tablet	628,918 L.L
B05BB02	5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml		Injectable solution	226,388 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS R	G	Potassium chloride - K+:1.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.40 mmol/l, Sodium acetate - Cl-:105.8 mmol/l, Sodium chloride - Na+:140.5 mmol/l		Injectable solution	L.L
C08CA01	AMLOCARD 10	G	Amlodipine (besylate) - 10mg	10mg	Tablet	870,298 L.L
C09DB07	CORONOPINE	G	Candesartan cilexetil - 16mg, Amlodipine - 5mg		Capsule, hard	1,638,144 L.L
J01DH02	AROPEM	G	Meropenem - 0.5g	0.5g	Injectable powder for solution	995,723 L.L

National Cancer Registry (NCR)